Form 4/A for MYGN MYRIAD GENETICS INC
Accepted 2024-03-28 00:00:00 ET · period of report 2024-03-14 · accession 0001832406-24-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 2024-03-28 | 2024-03-14 | MYGN | Leffler Scott J. | CFO | A - Grant | $0.00 | +46.9K | 164.7K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-14 | A | A | 46,905 | $0.00 | 164,675 | D | — | — | (F2) This amendment corrects the number of restricted stock units granted to the reporting person on March 14, 2024, which was incorrectly under reported by 810 restricted stock units on the original filing as a result of a clerical error. |